Markus Mayrhofer

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer et al. · Clinical Cancer Research · 2018 · 171 citations · Full text

Medicine, Oncology, Pharmacology +17

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns

Bram De Laere, Pieter‐Jan van Dam, Tom Whitington et al. · European Urology · 2017 · 141 citations

Medicine, Molecular Biology, Oncology +17

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus Mayrhofer, Bram De Laere, Tom Whitington et al. · Genome Medicine · 2018 · 132 citations · Full text

Medicine, Molecular Genetics, Oncology +17

On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth

Anette‐Gabriele Ziegler, B. Hillebrand, Wolfgang Rabl et al. · Diabetologia · 1993 · 117 citations · Full text

Life Sciences, Endocrinology, Immunology +14

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

Johnathan Watkins, Daniel Weekes, Vandna Shah et al. · Cancer Discovery · 2015 · 113 citations · Full text

Medicine, Genetics, Oncology +17